News for Healthier Living

Smart Nanoparticles Turn 'Cold' Tumors Hot: A New Era in Cancer Immunotherapy

Scientists have developed smart polymeric nanoparticles that respond to unique signals within the tumor microenvironment to deliver immunotherapy precisely where needed. The approach overcomes a major hurdle in cancer treatment: the inability of current immunotherapies to work against so-called "cold" tumors that lack immune cell infiltration. By responding to acidic pH, elevated enzymes, reactive oxygen species (ROS), glutathione (GSH), hypoxia, and adenosine triphosphate (ATP) overexpression, these nanoparticles trigger controlled drug release specifically at tumor sites. The strategy significantly enhances antitumor immune responses while reducing systemic toxicity, offering a promising path to make immunotherapy effective for more patients.

May 14, 2026


May 15 2026

May 14 2026

May 13 2026

May 12 2026

May 11 2026

May 10 2026

May 8 2026

May 7 2026

May 6 2026

May 5 2026

May 4 2026

May 1 2026